Table 1.
Summary of the effects of various mammalian sirtuins, their localization, and intracellular targets
| Sirtuin and localization | Enzymatic activity | Targets and substrates | Function | Tissue expression | Ageing and age-related diseases | |||
|---|---|---|---|---|---|---|---|---|
| Modification | Activation | Inhibition | Increase/involvement in CR | Decrease | ||||
| SIRT1 nuclear/cytosolic | Deacetylase | H1, H3, H4, (H1K26, H1K9, H3K9, H3K56, H3K14, H4K16) α tubulin, p53-(stabilization) | Suv39h1, LKB1, AMPK, NBS1, XPA, Mn-SOD, WRN, Ku70 | NFκB, p300, p66shc, mTOR | DNA repair, glucose metabolism, differentiation, neuroprotection, insulin secretion, vascular protection | Brain, adipose tissue, heart, kidney, liver, retina, skeletal muscle, vessels, uterus | Cell survival, longevity, physical activity/increase in CR | Cellular senescence, oxidative stress, inflammation, neurodegeneration, cardiovascular diseases, adiposity, insulin resistance, liver steatosis |
| FOXO, PGC-1α | ||||||||
| SIRT2 cytosolic/nuclear | Deacetylase | α tubulin, H4K16 | FOXO | NFκB, p53 | Cell-cycle control (transition from G2 to M phase), adipose tissue development and functionality | Adipose tissue, brain, heart, kidney, liver, skeletal muscle, vessels | Longevity/increase in CR | Oxidative stress, neurodegeneration |
| SIRT3 mitochondrial/nuclear/cytosolic | Deacetylase | H3, H4 (H3K9, H4K16) | FOXO, Ku70, Mn-SOD, catalase, IDH2 | p53, HIF1α | Regulation of mitochondrial metabolism, ATP production | Adipose tissue, brain, heart, kidney, liver, oocytes, skeletal muscle, vessels | Longevity, metabolic health, glucose homeostasis/increase in CR | Oxidative stress, neurodegeneration, cardiac hypertrophy, adiposity, liver steatosis |
| SIRT4 mitochondrial | ADP-ribosyl-transferase | GDH, AMPK | Insulin secretion, regulation of mitochondrial metabolism, DNA repair | Brain, heart, kidney, liver, vessels, pancreatic β-cells | Fatty acid oxidation | |||
| SIRT5 mitochondrial/cytosolic/nuclear | Deacetylase demalonylase desuccinylase | SOD1 | Urea cycle | Brain, heart, kidney, liver, vessels, thymus, testis, skeletal muscle | Increase in CR | Oxidative stress, fatty acid oxidation | ||
| SIRT6 nuclear (associated with chromatin) | Deacetylase, ADP-ribosyl-transferase | H2B, H3 (H2BK12, H3K9, H3K56), WRN (stabilization) | FOXO, PARP1, CtIP | NFκB, IGF-1 | DNA repair, telomere protection, genome stability, cholesterol homeostasis, regulation of glycolysis and gluconeogenesis | Brain, heart, kidney, liver, vessels, retina, skeletal muscle, thymus, testis, ovary | Longevity, glucose homeostasis/increase in CR | Cardiac hypertrophy, adiposity, liver steatosis, inflammation, insulin resistance |
| SIRT7 nucleolar/nuclear | Deacetylase | H2A, H2B, H3 (H3K18) | FOXO | RNA poly-merase I | Regulation of rRNA transcription, cell cycle regulation, cardioprotection | Heart, vessels, liver, brain, skeletal muscle, peripheral blood cells, spleen, testis | Increase in CR | Cardiac hypertrophy |
AMPK AMP-dependent kinase, CtIP C-terminal binding protein interacting protein, DNA-PKcs DNA-dependent protein kinase catalytic subunit, FOXO (FOXO3a, FOXO1) Forkhead box “O” transcription factor, GDH glutamate dehydrogenase, H1, H2A, H2B, H3, H4 histone; HIF1α hypoxia-inducible factor 1α, IGF-1 insulin-like growth factor 1, IDH2 isocitrate dehydrogenase 2, LKB1 liver kinase B1, Mn-SOD manganese superoxide dismutase, mTOR mammalian target of rapamycin, NBS1 Nijmegen breakage syndrome 1, NFκB nuclear factor κB, PARP1 poly(ADP-ribose) polymerase 1, PGC-1α PPARγ coactivator1α, SOD1 superoxide dismutase 1, Suv39H1 suppressor of variegation 3–9 homolog 1, WRN Werner syndrome ATP-dependent helicase, XPA xeroderma pigmentosum group A